Key Pharmaceuticals Limited

Key Pharmaceuticals Limited is a pharmaceutical company focused on developing and supplying high-quality generic drugs, alongside regulatory consultancy and project management services, meeting diverse healthcare needs globally. Founded in 2000, Key Pharmaceuticals Limited specializes in the development of generic pharmaceuticals. The company operates from its headquarters in the UK and has established itself as a significant player in the pharmaceutical industry, without any noted pivots or changes in business strategy. The founder's history is not specified, and there are no mentions of subsidiaries or parent companies.

Key Pharmaceuticals specializes in the development and supply of high-quality generic pharmaceuticals, regulatory consultancy, and project management for research and development. Their core offerings include a comprehensive portfolio of approved drug dossiers, successfully registered and launched in the UK and marketed internationally across six continents. With 20 years of experience, the company ensures that its products meet stringent regulatory requirements, providing effective solutions to healthcare providers and patients. Their client base primarily comprises pharmaceutical companies that seek to license generic products and require regulatory support and project management services, addressing various therapeutic needs through innovative drug formulations.

Key Pharmaceuticals operates on a B2B model, generating revenue through partnerships and licensing agreements with other pharmaceutical companies. The business transactions typically involve out-licensing drug dossiers, granting clients access to approved products for distribution in their respective markets. While specific pricing plans for individual products are not disclosed, revenue is derived from the successful registration and launch of products, including flagship offerings like Amiodarone Tablets. The company's established rapport with regulatory bodies and extensive project management experience enhances its value proposition, ensuring a reliable supply of pharmaceuticals.